For men with aggressive prostate cancer, few treatment options are available. A new drug, however, showed a positive effect in reducing the number of tumor cells and cancer markers in advanced prostate cancer.

Prostate cancer is the most common non-skin cancer in men. While some specialty organizations recommend that screening begin at age 40, there is little evidence showing real benefits to screening at this age.

The brain releases a hormone to help with sleep when it’s dark called melatonin. But what happens with night workers? Is there danger in not generating any melatonin?

After prostate cancer patients receive treatment, they still run the risk of the disease coming back. A newly approved imaging agent offers a way to detect recurrence earlier.

Silodosin ( Rapaflo ) is used to treat enlarged prostate, or benign prostatic hyperplasia ( BPH ). The drug, however, may trigger an ejaculatory disorder.

For some snorers, sleep apnea—a condition that momentarily blocks breathing—can lead to sleep deprivation and health problems, including erectile dysfunction.

Stents are used to open arteries that have narrowed from heart disease. Now doctors are considering them to treat erectile dysfunction to open the artery that supplies blood to the penis.

Prostate cancer surgery patients commonly experience erectile dysfunction. While many seek therapy to regain function, they may need more partner support to stay with the program.

Just over half of men between the ages of 40 and 70 have some degree of erectile dysfunction (ED). For those with complete ED, tadalafil may offer a lift.

There are a wide range of risk factors for heart arrhythmias, but could a symptom such as simple inflammation be enough to increase your risk?